Share this post on:

Product Name :
BAW2881 (NVP-BAW2881)

CAS No.:
861875-60-7

Purity :
> 99%

Shipping:
Shipped on dry ice.

Storage :
Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month

SMILES:
NC1=NC(=CC=N1)OC2=CC=C3C(=C2)C=CC=C3C(=O)NC4=CC(=CC=C4)C(F)(F)F

Product Description :
BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor tyrosine-kinase inhibitor that potently inhibits VEGFR1-3 at 1.{{2815296-08-1} MedChemExpress|{2815296-08-1} Purity & Documentation|{2815296-08-1} In Vitro|{2815296-08-1} custom synthesis} 0-4.3 nanomolar (nM) concentrations and inhibits PDGFRβ, c-Kit, and RET at 45-72 nM concentrations.

Formula:
C22H15F3N4O2

Molecular Weight :
424.38

Synonyms:

Additional Information:
|CAS No. 861875-60-7 ; |Formula C22H15F3N4O2 ; |Molecular Weight 424.38 ; |SMILES NC1=NC(=CC=N1)OC2=CC=C3C(=C2)C=CC=C3C(=O)NC4=CC(=CC=C4)C(F)(F)F ; |Target VEGFR1-3 ; |Product Description BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor tyrosine-kinase inhibitor that potently inhibits VEGFR1-3 at 1.{{134678-17-4} MedChemExpress|{134678-17-4} Purity & Documentation|{134678-17-4} Purity|{134678-17-4} custom synthesis} 0-4.PMID:30000459 3 nanomolar (nM) concentrations and inhibits PDGFRβ, c-Kit, and RET at 45-72 nM concentrations. ; |Purity > 99% ; |Shipping Shipped on dry ice. ; |Storage Powder: -20 °C, 3 years; 4 °C, 2 yearsIn solvent: -80 °C, 6 months; -20 °C, 1 month ; |Solubility Overview Soluble in DMSO

MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com

Share this post on: